Russell Investments Group
ENFN

Russell Investments Group’s Enfusion, Inc. ENFN Stock Holding History

Russell Investments Group’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-163
Closed -$1.82K – 3987
2025
Q1 		$1.82K Buy
163
+86
+112% +$951 ﹤0.01% 3528
2024
Q4 		$793 Hold
77
– – ﹤0.01% 3553
2024
Q3 		$731 Buy
+77
New +$664 ﹤0.01% 3523
2023
Q2 		– Sell
-25,691
Closed -$270K – 3547
2023
Q1 		$270K Buy
+25,691
New +$283K ﹤0.01% 2420

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Russell Investments Group's ENFN Position: Q2 2025 in Review

Russell Investments Group sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 163 shares — an estimated $1.82K sold.

Russell Investments Group first reported a position in ENFN in Q1 2023 and held it in 4 quarters. The position peaked at $270K in Q1 2023. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Russell Investments Group reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Russell Investments Group sold 163 Enfusion, Inc. shares in Q2 2025, an estimated $1.82K.
  • Russell Investments Group first reported a position in Enfusion, Inc. in Q1 2023 and held it in 4 quarters.
  • Russell Investments Group's Enfusion, Inc. position peaked at $270K in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Russell Investments Group's 13F filing for Q2 2025, filed 13 Aug 2025.